These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6661085)

  • 1. [Myocardial protection in cardiac surgery. Comparison of 2 cardioplegic solutions].
    Pereira SN; Ribeiro CT; Raiser AG; Tabone EJ; Andujar MB; Marques RS
    Arq Bras Cardiol; 1983 Apr; 40(4):255-8. PubMed ID: 6661085
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myocardial protection from cardioplegic and hypothermia during aortic cross-clamping (author's ttrans)].
    Di Summa M; Carletta C; Morea M
    G Ital Cardiol; 1979; 9(3):295-301. PubMed ID: 456788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of the oxygenation of cardioplegic solutions for myocardial protection in cardiac surgery].
    Gomes OM
    Arq Bras Cardiol; 1984 Dec; 43(6):389-96. PubMed ID: 6537762
    [No Abstract]   [Full Text] [Related]  

  • 4. Preservation of cardiac myocytes subjected to different preconditions: a comparative morphometric study of beating, fibrillating, and cardioplegically arrested canine hearts.
    Schmiedl A; Schnabel PA; Richter J; Mall G; Bretschneider HJ
    Anat Rec; 1993 Mar; 235(3):425-35. PubMed ID: 8430912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial preservation during anoxic arrest. Chemical cardioplegia.
    Vejlsted H; Andersen K; Husum B; Fischer Hansen B; Arnbjerg J
    Scand J Thorac Cardiovasc Surg; 1983; 17(3):265-8. PubMed ID: 6417774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of blood-based and crystalloid cardiopneumoplegic solutions in heart and lung preservation for 24 hours: an ultrastructural morphometric study in dogs.
    Tédy G; Corbi P; Rabago G; Muneretto C; Pavie A; Chomette G; Cabrol C; Gandjbakhch I
    Transplant Proc; 1993 Jun; 25(3):2222-5. PubMed ID: 8516878
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-ischemic protection of the myocardium by cardioplegic solutions].
    Onishchenko NA; Lubiako AA
    Vestn Akad Med Nauk SSSR; 1985; (4):40-7. PubMed ID: 4013508
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative myocardial protection with calcium-free versus calcium-containing potassium cardioplegic solutions.
    Magee PG; Gardner TJ; Flaherty JT; Bulkley BH; Goldman RA; Gott VL
    J Surg Res; 1980 Aug; 29(2):161-71. PubMed ID: 7412259
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
    Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
    J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aortic valve replacement in cardioplegic heart arrest].
    Stenzl W; Kraft-Kinz J; Rigler B; Tscheliessnigg KH; Hermann W; Dacar D; Metzler H; Rebak P
    Wien Med Wochenschr; 1983 May; 133(10):253-6. PubMed ID: 6880212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observation on myocardial ultrastructure in myocardial protection with cold potassium-magnesium-energy cardioplegic solution].
    Jiang TF
    Zhonghua Wai Ke Za Zhi; 1982 Nov; 20(11):646-8, 701. PubMed ID: 7182140
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions.
    Hearse DJ; O'Brien K; Braimbridge MV
    J Thorac Cardiovasc Surg; 1981 Jun; 81(6):873-9. PubMed ID: 7230856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New methods of myocardial protection for cardiac surgery.
    Kay H; Laks H; Hammond GL; Geha AS
    Conn Med; 1980 Jun; 44(6):357-61. PubMed ID: 6995003
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cardioplegic solutions on conductive coronary arteries.
    Chiavarelli M; Toscano M; Chiavarelli R; Carpi A; Marino B
    J Thorac Cardiovasc Surg; 1982 Jul; 84(1):23-7. PubMed ID: 6806545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Animal experiment evaluation of myocardial protection with a magnesium-asparaginate-procaine solution].
    Walpoth B; Fornaro M; von Gossler W; Turina M
    Chir Forum Exp Klin Forsch; 1978; (1978):99-102. PubMed ID: 752612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ultrastructural diagnosis of changes in the human myocardium during protection of the heart with cardioplegic solutions].
    Mogilevskiĭ GM; Krymskiĭ LD; Sharov VG
    Arkh Patol; 1986; 48(11):39-45. PubMed ID: 3827622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and cardioplegia. The optimal calcium content for the St. Thomas' Hospital cardioplegic solution.
    Yamamoto F; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):908-12. PubMed ID: 6727412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidose blood versus crystalloid cardioplegia. Comparison by quantitative assessment of irreversible myocardial injury.
    Feindel CM; Tait GA; Wilson GJ; Klement P; MacGregor DC
    J Thorac Cardiovasc Surg; 1984 Apr; 87(4):585-95. PubMed ID: 6708578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reperfusion effects on the magnesium-procaine arrested rabbit heart.
    Hölscher B
    Arzneimittelforschung; 1981; 31(11):1881-4. PubMed ID: 7198469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.